Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway

Choice of direct acting antiviral (DAA) therapy for Hepatitis C Virus (HCV) in the United Kingdom and similar settings usually requires knowledge of the genotype and, in some cases, antiviral resistance (AVR) profile of the infecting virus. To determine these, most laboratories currently use Sanger...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Microbiol
Auteurs principaux: Manso, Carmen F., Bibby, David F., Lythgow, Kieren, Mohamed, Hodan, Myers, Richard, Williams, David, Piorkowska, Renata, Chan, Yuen T., Bowden, Rory, Ansari, M. Azim, Ip, Camilla L. C., Barnes, Eleanor, Bradshaw, Daniel, Mbisa, Jean L.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Microbiology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7583327/
https://ncbi.nlm.nih.gov/pubmed/33162957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.576572
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires